Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucagon for acute severe asthma attack
IRCT20131118015446N13Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Oct 2017
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Glucagon plus standard treatment with Placebo plus standard treatment (2 arms). Primary endpoints: PEFR and FEV1. Started Oct 2017; status: completed.
02
Drugs
glucagon
03
Conditions
asthma
Beyond the preview
Go deeper on IRCT20131118015446N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20131118015446N13.